Real-time enrollment status for this alcoholic liver disease clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 12:37 AM UTC
| NCT Number | NCT06613698 |
| Recruiting Status | Recruiting |
| Condition | Alcoholic Liver Disease |
| Phase | PHASE2 |
| Target Enrollment | 393 participants |
| Active Locations | 27 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | April 1, 2026 (Apr 1, 2026) |
As of July 20, 2026: Clinical trial NCT06613698 is currently recruiting participants. This phase2 study for alcoholic liver disease is actively seeking new participants at 27 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06613698 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06613698 was last updated Apr 1, 2026 (April 1, 2026). HelloStudys verifies this status automatically.